Movement Alert｜Intuitive Surgical Intraday Decline 3.18% in Regular Trading, prior board appointment optimism fades as target-price support proves limited

Market Focus11-06

On November 6, Intuitive Surgical fell 3.18% in Regular Trading, trading at $466.825 per share, with turnover of $964 million.

The recent backdrop centers on the company’s appointment of Aaron Martin to its board and a fresh round of analyst target-price revisions, but the latest adjustment was modest, with HSBC raising its target price to $392 from $391, still below the broader analyst mean target of $489.61, limiting incremental support for sentiment.

Earlier, several firms had raised targets, including Daiwa to $490, Rothschild & Co Redburn to $560, and JPMorgan to $475, while Evercore ISI had cut its target to $375. The company’s third-quarter results had exceeded expectations, with adjusted EPS of $3.00 and revenue of $3.049 billion, but management also tightened its procedure-growth outlook, leaving investors balancing strong execution against slower growth expectations.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment